Published in Eur J Immunol on May 01, 1986
Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius. Infect Immun (1992) 0.84
Specific maternal anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors. Clin Exp Immunol (1989) 0.81
A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Two distinct factors are required for induction of T-cell growth. Nature (1980) 4.13
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
The role of mitogenic lectins in T-cell triggering. Nature (1979) 3.26
Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte. Cell (1977) 3.23
Second generation immune networks. Immunol Today (1991) 2.97
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry (2005) 2.78
Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages. J Exp Med (1977) 2.68
Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors. Eur J Immunol (1979) 2.59
Extrathymic origin of intestinal intraepithelial lymphocytes bearing T-cell antigen receptor gamma delta. Proc Natl Acad Sci U S A (1991) 2.46
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32
Bub3 interaction with Mad2, Mad3 and Cdc20 is mediated by WD40 repeats and does not require intact kinetochores. EMBO J (2001) 2.31
Specific T helper cells that activate B cells polyclonally. In vitro enrichment and cooperative function. J Exp Med (1980) 2.27
Localization of gamma/delta T cells to the intestinal epithelium is independent of normal microbial colonization. J Exp Med (1990) 2.23
Selective triggering of B cell subpopulations by mitogens. Eur J Immunol (1974) 2.22
Genetic aspects in sarcoidosis. Eur Respir J (2000) 2.20
Functional analysis of B cell heterogeneity. Transplant Rev (1975) 2.17
High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17
Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J (1996) 2.15
Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nat Med (2000) 2.01
Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg (1994) 1.90
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur J Immunol (1977) 1.83
All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol (1990) 1.82
Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature (1993) 1.82
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Genetic control of B-cell responses. I. Selective unresponsiveness to lipopolysaccharide. Scand J Immunol (1975) 1.71
Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol (1997) 1.70
Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin. Mol Biol Cell (1999) 1.66
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Nanobacteria: an infectious cause for kidney stone formation. Kidney Int (1999) 1.59
Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57
Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg (1996) 1.56
Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%. Exp Cell Res (1978) 1.55
A novel cell surface molecule on early B-lineage cells. Nature (1986) 1.55
Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells. Immunol Rev (1989) 1.53
Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol (1997) 1.53
Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38. Eur J Biochem (1994) 1.53
Thymic epithelium tolerizes for histocompatibility antigens. Science (1990) 1.53
The switch from IgM to IgG secretion in single mitogen-stimulated B-cell clones. J Exp Med (1978) 1.52
Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev (1996) 1.50
'What if they ask how I got it?' Dilemmas of disclosing parental HIV status and testing children for HIV in Uganda. Health Policy Plan (2008) 1.50
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol (1996) 1.46
Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses. Scand J Immunol (1986) 1.46
Are lymphocytes concerned with our definition of idiotypes? Immunol Today (1993) 1.44
Continuous growth of mitogen-reactive B lymphocytes. Scand J Immunol (1975) 1.43
Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods (1998) 1.41
G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J Biol Chem (1995) 1.41
The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem (1994) 1.41
IgM antibodies induce the production of antibodies of the same specificity. Proc Natl Acad Sci U S A (1980) 1.40
Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia (1993) 1.40
Immunoglobulin C-gene expression. I. The commitment to IgG subclass of secretory cells is determined by the quality of the nonspecific stimuli. Eur J Immunol (1980) 1.39
Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol (1993) 1.38
The CD2 antigen associates with the T-cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes. Nature (1989) 1.37
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. J Cell Biol (1998) 1.36
Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase. J Biol Chem (1993) 1.33
In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32
The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol (1997) 1.32
Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies. J Immunol (1987) 1.31
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol (1986) 1.29
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med (1997) 1.28
Mitogen-activated B-cell blasts reactive to more than one mitogen. J Exp Med (1979) 1.28
Heterogeneity of B cells: direct evidence of selective triggering of distinct subpopulations by polyclonal activators. Scand J Immunol (1976) 1.27
Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells. Ann Inst Pasteur Immunol (1988) 1.27
Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3. Eur J Immunol (1973) 1.26
Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis. Trop Med Int Health (1996) 1.26
Regulation of T cell autocrine growth. T4+ cells become refractory to interleukin 2. J Exp Med (1986) 1.26
Reactions among IgM antibodies derived from normal, neonatal mice. Eur J Immunol (1984) 1.24
Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease. J Immunol (1986) 1.24
Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia (1993) 1.23
Genetic and functional characterization of an antiserum to the lipid A-specific triggering receptor on murine B lymphocytes. Eur J Immunol (1978) 1.23
Administration to mouse of endotoxin from gram-negative bacteria leads to activation and apoptosis of T lymphocytes. Eur J Immunol (1998) 1.23
Genetical control of B-cell responses. III. Requirement for functional mitogenicity of the antigen in thymus-independent specific responses. J Exp Med (1975) 1.23
Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr. Eur J Biochem (1994) 1.23
Antibody repertoires of normal BALB/c mice: B lymphocyte populations defined by state of activation. Immunol Rev (1986) 1.22
The theory of the 'one nonspecific signal' model for b cell activation. Transplant Rev (1975) 1.21
Population dynamics of B lymphocytes and their precursors: demonstration of high turnover in the central and peripheral lymphoid organs. J Immunol (1982) 1.21
Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors. Eur J Immunol (1978) 1.20
Renal abnormalities in microfilaremic patients with Bancroftian filariasis. Am J Trop Med Hyg (1992) 1.20
B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. Proc Natl Acad Sci U S A (1982) 1.19
An antiserum which recognizes lipopolysaccharide-reactive B cells in the mouse. Eur J Immunol (1978) 1.19
Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction. Eur J Immunol (1977) 1.19
Genetical control of B-cell responses. IV. Inheritance of the unresponsiveness to lipopolysaccharides. J Exp Med (1975) 1.19
Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci U S A (1995) 1.18
Regulation of T cell growth factor production: arrest of TCGF production after 18 hours in normal lectin-stimulated mouse spleen cell cultures. J Immunol (1981) 1.18
Global analysis of antibody repertoires. II. Evidence for specificity, self-selection and the immunological "homunculus" of antibodies in normal serum. Eur J Immunol (1993) 1.16
Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. Int Immunol (1991) 1.16
Isotypic pattern of the polyclonal B cell response during primary infection by Plasmodium chabaudi and in immune-protected mice. Eur J Immunol (1987) 1.15
A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol Rev (1996) 1.15